We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Ameresco
AMRC
$1.37B
| $202K | ﹤0.01% |
27,246
+1,300
| +5% | +$8.58K |
|
|
RPRX
2827
DELISTED
Repros Therapeutics Inc.
RPRX
| $202K | ﹤0.01% |
23,490
+3,900
| +20% | +$34.9K |
|
|
KYNB
2828
Kyntra Bio
KYNB
$28.3M
| $200K | ﹤0.01% |
+255
| New | +$198K |
|
2829
Xencor
XNCR
$1.47B
| $200K | ﹤0.01% |
13,045
+2,200
| +20% | +$34.7K |
|
|
OMCC
2830
DELISTED
Old Market Capital Corp
OMCC
| $200K | ﹤0.01% |
14,251
+700
| +5% | +$10.3K |
|
2831
Applied Optoelectronics
AAOI
$10.1B
| $199K | ﹤0.01% |
14,360
+2,800
| +24% | +$30.7K |
|
2832
Lineage Cell Therapeutics
LCTX
$284M
| $199K | ﹤0.01% |
49,613
+12,143
| +32% | +$42K |
|
|
WW
2833
DELISTED
WW International
WW
| $199K | ﹤0.01% |
28,474
+3,110
| +12% | +$45.9K |
|
2834
Jakks Pacific
JAKK
$292M
| $198K | ﹤0.01% |
2,888
+130
| +5% | +$8.42K |
|
2835
Regional Management Corp
RM
$304M
| $198K | ﹤0.01% |
13,425
+700
| +6% | +$10.8K |
|
|
ECOM
2836
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $197K | ﹤0.01% |
20,338
+3,900
| +24% | +$43.3K |
|
|
STML
2837
DELISTED
Stemline Therapeutics, Inc.
STML
| $197K | ﹤0.01% |
+13,598
| New | +$208K |
|
|
SNC
2838
DELISTED
State National Companies, Inc.
SNC
| $197K | ﹤0.01% |
19,800
+3,250
| +20% | +$32.4K |
|
2839
Consumer Portfolio Services
CPSS
$206M
| $193K | ﹤0.01% |
27,568
+1,400
| +5% | +$9.39K |
|
|
CDMO
2840
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $191K | ﹤0.01% |
20,183
+4,543
| +29% | +$43.7K |
|
|
SGM
2841
DELISTED
Stonegate Mortgage Corporation
SGM
| $190K | ﹤0.01% |
17,545
+1,400
| +9% | +$14.7K |
|
|
PBPB
2842
DELISTED
Potbelly
PBPB
| $188K | ﹤0.01% |
13,715
+2,800
| +26% | +$38.9K |
|
2843
Ring Energy
REI
$317M
| $188K | ﹤0.01% |
17,690
+3,900
| +28% | +$37.1K |
|
2844
Safe Bulkers
SB
$785M
| $188K | ﹤0.01% |
52,395
+2,600
| +5% | +$9.39K |
|
|
MCBC
2845
DELISTED
Macatawa Bank Corp
MCBC
| $188K | ﹤0.01% |
35,157
+1,800
| +5% | +$9.62K |
|
|
ZEUS
2846
DELISTED
Olympic Steel
ZEUS
| $187K | ﹤0.01% |
13,905
+800
| +6% | +$11.8K |
|
2847
Equinor
EQNR
$93.8B
| $186K | ﹤0.01% |
+10,557
| New | +$188K |
|
|
B
2848
Barrick Mining
B
$69B
| $186K | ﹤0.01% |
16,960
| – | – |
|
2849
Donegal Group Class A
DGICA
$720M
| $184K | ﹤0.01% |
11,690
+500
| +4% | +$7.85K |
|
2850
Twin Disc
TWIN
$347M
| $184K | ﹤0.01% |
+10,436
| New | +$189K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.